Email this article 
Assessing the Economic Implications of a Diagnosis‑Related Groups Payment System in Iran’s Health System Transformation Plan
Abstract
Background: The Health System Transformation Plan (HSTP) in Iran aimed to enhance universal health coverage through improved access and reduced out‑of‑pocket payments. However, rising healthcare expenditures have posed challenges. The Diagnosis‑Related Groups (DRG) payment system has been implemented in developed countries to reduce costs, improve efficiency, and enhance service quality. This study estimates the potential cost savings in pharmaceutical and inpatient services within the HSTP framework, focusing on public hospitals affiliated with Isfahan University of Medical Sciences (MUI). Methods: This study was conducted in three stages. First, a cross‑sectional study design was used to collect current inpatient and pharmaceutical costs from public hospitals affiliated with MUI before and after the health sector reform. Second, a meta‑analysis was conducted to determine the effects of implementing the DRG payment system on the costs of inpatient and pharmaceutical services. Finally, the possible costs of medication and hospitalization in 2015 were estimated by applying the annual inflation rate. The predicted costs were calculated by multiplying the impact values of the DRG payment system on the estimated expenses in 2015. The potential cost savings were calculated by subtracting the current expenses from the predicted expenses based on the DRG payment system. Results: Based on the assumption ratio of changes following the implementation of the DRG payment system, the study estimated cost savings of $60,282,055 in both inpatient and pharmaceutical expenses. Conclusions: Implementing the DRG payment system could have resulted in significant cost savings, equivalent to 9.2% of the total health sector expenditures of MUI.
International Journal of Preventive Medicine 16():22, April 2025. | DOI: 10.4103/ijpvm.ijpvm_359_23
Corresponding Author: Dr. Reza Khadivi
E‑mail:khadivi@med.mui.ac.ir
You can also search for this author in: PubMed Google Scholar
Keywords
Full Text:
PDFReferences
Sajadi H, Hosseini M, Dehghani A, Khodayari R, Zandiyan H, Hosseini H. The policy analysis of Iran’s health transformation plan in therapeutic services. Hakim Health Systems Research Journal 2018;21:71-88.
Bodenheimer TS, Grumbach K. Understanding Health Policy, Fifth Edition: LSC LS4(EDMC) Vitalsource Ebook Understanding Health Policy, Fifth Edition. McGraw-Hill Education; 2008.
Mosadeghrad AM, Mirzaee N, Afshari M, Darrudi A. The impact of health transformation plan on health services fees: Brief Report. Tehran University Medical Journal. 2018;76:277-82.
Roberts M, Hsiao W, Berman P, Reich M. Getting Health Reform Right: A Guide to Improving Performance and Equity. Oxford University Press; 2008.
Khadivi R, Rezayatmand M, Bank H, Etesampor A, Ghasemi N. The comparison of direct health expenditures of selected insurance organizations of Isfahan Province and Isfahan University of Medical Sciences, Iran, before and after Health Care Reform in Years 2013 and 2015. Health Information Management. 2019;15:274-80.
World Health Organization, Mathauer I, Wittenbecher F. DRGbased payments systems in low- and middle-income countries: Implementation experiences and challenges. Geneva: World Health Organization; 2012.
Chilingerian J. Origins of DRGs in the United States: A technical, political and cultural story. In: Kimberly J, de Pouvourville G, d'Aunno T, editors. The Globalization of Managerial Innovation in Health Care. Cambridge: Cambridge University Press; 2008. p. 4-33.
Ghaffari SH, Abolhallaj M, Pouragha B. Feasibility of implementing diagnosis related groups: A case study in Iran’s Hospitals. Hakim Health Systems Research Journal. 2012;15:147-57.
Panagiotopoulos P, Maniadakis N, Papatheodoridis G, Pektasidis D. An evaluation of Diagnosis-Related Group (DRG) implementation focused on cancer DRGs in Greek Public Hospitals. Pharmacoecon Open 2020;4:61-9. doi: 10.1007/ s41669-019-0146-z.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley and Sons, 2019.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
Jian W, Lu M, Chan KY, Poon AN, Han W, Hu M, et al. Payment reform pilot in Beijing hospitals reduced expenditures and out-of-pocket payments per admission. Health Affairs. 2015;34:1745-52. [doi: 10.1377/hlthaff.2015.0074].
Lave JR, Frank RG, Taube C, Goldman H, Rupp A. The early effects of Medicare’s prospective payment system on psychiatry. Inquiry 1988;25:354-63.
Kwak JM, Lee KS. Is the hospital caseload of diagnosis related groups related to medical charges and length of stay? The Korean Journal of Health Service Management. 2014;8:13-24.
Kwak SH, Kim JH, Kim DH, Kim JM, Byeon HK, Kim WS, et al. Impact of the Korean Diagnosis-Related Groups payment system on the outcomes of adenotonsillectomy: A single center experience. Auris Nasus Larynx. 2018;45:504-7.
Suwei Y, Wenwei L, Fengqing W, Haichen Zhang SW, Weijun Z, Jin M. Impacts of hospital payment based on Diagnosis Related Groups (DRGs) with global budget on resource use and quality of care: A case study in China. Iranian journal of public health 2019;48:238.
Shin SC, Kim JS. A study of simulations on the changes of Physician’s practice patterns in University Hospitals after the introduction of DRG in obstetrics and gynecology. Journal of Digital Convergence. 2013;11:289-98.
Jung YW, Pak H, Lee I, Kim EH. The effect of diagnosis-related group payment system on quality of care in the field of obstetrics and gynecology among Korean tertiary hospitals. Yonsei medical journal 2018;59:539-45.
Cao Q, Tan J, Wang W, Liu Y, Zhang G, Zhao S. Empirical analysis on the effects of single-disease quota payment in Chengdu based on difference-in-difference model.Chinese Journal of Evidence-Based Medicine 2018;18:807-11.
Song S-Y, Lee E-K. Comparative analysis of drug use for the uterine and adnexa patients after the introduction of DRG. Journal of Korean Society for Clinical Pharmacology and Therapeutics. 2000;8:248-64.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐ analysis. Statistics in medicine 2002;21:1539-58.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
Egger M, Smith GD, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. Bmj. 1997;315:62934.
Central Bank of the Islamic Republic of Iran. Rial to dollar exchange rate from 1990 to 2023. 2023. Available from: https:// www.cbi.ir/exrates/rates_fa.aspx. [Last accessed on 2023 Dec 20].
Hadizade RT, Leila. Investigating the Producer Price Index of Service Sectors during the years 2011-2017. Statistical Center of Iran; 2015.
Iran Planning and Budget Organization. Iran annual budget plan. 2015. Available from: https://shenasname.ir/budjet/1394/2978law-budjet94. [Last accessed on 2023 Dec 20].
Thomson S, Osborn R, Squires D, Jun M. International Profiles of Health Care Systems, 2012: Australia, Canada, Denmark, England, France, Germany, Iceland, Italy, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States: Commonwealth Fund; 2013.
Annear PL, Kwon S, Lorenzoni L, Duckett S, Huntington D, Langenbrunner JC, et al. Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand. Health Policy (Amsterdam, Netherlands) 2018;122:707-13.
Busse R, Geissler A, Aaviksoo A, Cots F, Hakkinen U, Kobel C, et al. Diagnosis related groups in Europe: Moving towards transparency, efficiency, and quality in hospitals? BMJ 2013;346:f3197.
Moreno-Serra R, Wagstaff A. System-wide impacts of hospital payment reforms: Evidence from Central and Eastern Europe and Central Asia. Journal of Health Economics 2010;29:585-602.
Zou K, Li HY, Zhou D, Liao ZJ. The effects of diagnosis-related groups payment on hospital healthcare in China: A systematic review. BMC Health Services Research 2020;20:112.
Farrar S, Yi D, Sutton M, Chalkley M, Sussex J, Scott A. Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis. BMJ 2009;339:b3047.
Vulgaropulos SP, Lyle CB, Sessions JT. Potential economic impact of applying DRG-based prospective payment categories to inflammatory bowel disease patients. Digestive Diseases and Sciences. 1990;35:577-81.
Sarıyer G, Ataman MG, Kızıloğlu İ. Factors affecting length of stay in the emergency department: A research from an operational viewpoınt. International Journal of Healthcare Management 2020;13(Suppl 1):173-82.
Barouni M, Ahmadian L, Anari HS, Mohsenbeigi E. Challenges and adverse outcomes of implementing reimbursement mechanisms based on the diagnosis-related group classification system: A systematic review. Sultan Qaboos University Medical Journal 2020;20:e260-70.
Emanuel EJ, Zhang C, Glickman A, Gudbranson E, DiMagno SSP, Urwin JW. Drug Reimbursement Regulation in 6 Peer Countries. JAMA Internal Medicine 2020;180:1510-7.
Franken M, Le Polain M, Cleemput I, Koopmanschap M. Similarities and differences between five European drug reimbursement systems. International journal of technology assessment in health care 2012;28:349-57.
Garattini L, Padula A. Pharmaceutical expenditure control in Europe: Time to move from pricing to budgeting? Journal of the Royal Society of Medicine 2020;113:93-7.
World Health Organization Europe. Medicines reimbursement policies in Europe. 2018. Available from: https://iris.who. int/bitstream/handle/10665/342220/9789289053365-eng. pdf?sequence=1. [Last accessed on 2023 Dec 20].
Quentin W, Scheller-Kreinsen D, Blumel M, Geissler A, Busse R. Hospital payment based on diagnosis-related groups differs in Europe and holds lessons for the United States. Health Affairs. 2013;32:713-23.
Meng Z, Hui W, Cai Y, Liu J, Wu H. The effects of DRGsbased payment compared with cost-based payment on inpatient healthcare utilization: A systematic review and meta-analysis. Health policy (Amsterdam, Netherlands) 2020;124:359-67.
Casto AB, Forrestal E. Principles of healthcare reimbursement. Springfield, IL: American Health Information Management Association; 2013.
Rezaei P, Asadzadeh A. The approach of diagnosis-related groups and ambulatory payment classifications in the health payment system and providing a framework for using them in Iranian hospitals. Iranian Journal of Health Insurance. 2019;2:55-62.